Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease which cannot be cured at present. The aim of this study was to assess whether the combined application of β-asarone and tenuigenin could improve the efficacy of memantine in treating moderate-to-severe AD. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wenguang, Teng, Junfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842771/
https://www.ncbi.nlm.nih.gov/pubmed/29551889
http://dx.doi.org/10.2147/DDDT.S155567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842771/
https://www.ncbi.nlm.nih.gov/pubmed/29551889
http://dx.doi.org/10.2147/DDDT.S155567

Ejemplares similares